Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive subtype of peripheral T-cell lymphoma that requires specialized therapeutic approaches. Growing awareness of lymphoma disorders, advancements in diagnostic technologies, and the emergence of targeted therapies are contributing to increased treatment adoption worldwide. The Angioimmunoblastic T-Cell Lymphoma Treatment Market...